Balyasny Asset Management’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Balyasny Asset Management’s Portfolio HCAR Stock Details HCAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-300,878	Closed	-$2.99M	–	3429
2022 Q3	$2.99M	Sell	300,878 -26	-0%	-$257	0.01%	1276
2022 Q2	$2.96M	Hold	300,904	–	–	0.01%	1195
2022 Q1	$2.95M	Hold	300,904	–	–	0.01%	1194
2021 Q4	$2.94M	Hold	300,904	–	–	0.01%	1054
2021 Q3	$2.93M	Hold	300,904	–	–	0.01%	1002
2021 Q2	$2.91M	Buy	300,904 +23,000	+8%	+$223K	0.01%	896
2021 Q1	$2.69M	Buy	+277,904	New	+$2.79M	0.01%	929

Balyasny Asset Management's HCAR Position: Q4 2022 in Review

Balyasny Asset Management sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 300,878 shares — an estimated $2.99M sold.

Balyasny Asset Management first reported a position in HCAR in Q1 2021 and held it in 7 quarters. The position peaked at $2.99M in Q3 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

Balyasny Asset Management reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Balyasny Asset Management sold 300,878 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $2.99M.
Balyasny Asset Management first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q1 2021 and held it in 7 quarters.
Balyasny Asset Management's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $2.99M in Q3 2022.
0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.